The FDA last week announced that it had accepted the FACE-Q as a qualified Medical Device Development Tool (MDDT) – a decision that not only provides the agency with patient perspective when it comes to evaluating new aesthetic treatments, but also national recognition for an idea that came into being thanks to The PSF's grant funding.

Read more about this from ASPS on plasticsurgery.org